Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04550715 · ClinicalTrials.gov registry record · NA
Prevention Interventions for Opioid Misuse
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 1,155
- Enrollment target
NCT04550715: Completed NA study, sponsored by University of Michigan.
NCT04550715 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 1,155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04550715, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,155 participants
- Enrollment target
Study Summary
The purpose of the study is to develop and test innovative interventions to prevent the development of opioid misuse and opioid use disorders among older adolescents and young adults (AYA; ages 16-30) who use opioids, which will be initiated from a health care visit in the emergency department and extended post discharge via a telehealth approach. This study will have significant impact by identifying optimal, cost-effective opioid prevention strategies to sustain outcomes among AYAs.
Primary Outcome
Alcohol Smoking and Substance Involvement Screening Test severity risk score (severity of prescription opioids/heroin consumption and consequences, scores range 0-27 per subscale; the prescription opioid and heroin subscales are summed such that total possible range on this measure is 0-54, higher score indicates worse outcomes/more severity). Note: missing data was imputed and median scores are presented.
Interventions
- BEHAVIORAL Enhanced Usual Care (EUC)
- BEHAVIORAL Brief intervention (BI)
- BEHAVIORAL Portal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,155 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2025-04-14 |
| Phase | NA |
What the finished NCT04550715 record still lists
NCT04550715 is an interventional study that assigns participants to a tested intervention. Its 1,155 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower).
The record links to 0 conditions, and to 3 interventions - of which Enhanced Usual Care (EUC) is the first listed.
NCT04550715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04550715 about?
NCT04550715 is a clinical study titled "Prevention Interventions for Opioid Misuse". The purpose of the study is to develop and test innovative interventions to prevent the development of opioid misuse and opioid use disorders among older adolescents and young adults (AYA; ages 16-30) who use opioids, which will be initiated from a health care visit in the emergency department and e...
What is the current status of trial NCT04550715?
This trial is currently completed. It is a NA study. The enrollment target is 1,155 participants. The study started on 2021-01-04. Estimated completion is 2025-04-14.
What interventions are being tested in trial NCT04550715?
The interventions under investigation include: Enhanced Usual Care (EUC) (BEHAVIORAL), Brief intervention (BI) (BEHAVIORAL), Portal (BEHAVIORAL).
Who is sponsoring clinical trial NCT04550715?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04550715's enrollment target sits among peer trials
1,155 92nd of 2000 higher than 1,909 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT04577599 · 1,160 participants · NA
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
- NCT07082738 · 1,160 participants · Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI